Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
Clinical trial NCT04331119 · TERMINATED
Trial details
- NCT number
- NCT04331119
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2026-04-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.